Physician profile
John Costello
NPI 1952531212
$9,347.63
in general payments reported to CMS, 2019-2025
11 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,126 · 2020: $1,252 · 2021: $1,757 · 2022: $1,108 · 2023: $479 · 2024: $913 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,959.78 | 2019-2025 | Aveir, Ensite, Amplatzer Amulet |
| Medtronic Vascular, INC. | $1,826.44 | 2019-2020 | |
| Medical Device Business Services, INC. | $374.90 | 2019 | |
| Biosense Webster, INC. | $353.65 | 2019 | |
| Edwards Lifesciences Corporation | $250.60 | 2019 | |
| Boston Scientific Corporation | $168.39 | 2019 | |
| Zoll Respicardia, INC. | $143.55 | 2019 | |
| Corcym INC | $121.93 | 2022 | |
| Medtronic, INC. | $95.38 | 2022-2025 | Biomedicus, Avalus |
| Solventum Corporation | $37.64 | 2024-2025 | Prevena |
| Kls-Martin L.P. | $15.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Costello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.